Concomitant PIK3CA and TP53 Mutations in Breast Cancer: An Analysis of Clinicopathologic and Mutational Features, Neoadjuvant Therapeutic Response, and Prognosis.

Journal of breast cancer（2023）

引用 0|浏览2

暂无评分

摘要

Concomitant mutations not only suggested unfavorable features and poor prognosis in BC but also conferred less benefit to NST than mutations alone.

查看译文

关键词

breast cancer,neoadjuvant therapeutic response,mutations

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要